Page 68 - Read Online

Zanello et al. Rare Dis Orphan Drugs J 2023;2:9 https://dx.doi.org/10.20517/rdodj.2023.04 Page 15 of 15

33. Reagan-Udall Foundation for the FDA. Repurposing off-patent drugs: research & regulatory challenges. Available from: https://
reaganudall.salsalabs.org/repurposingoffpatentdrugsworkshop/index.html [Last accessed on 11 Apr 2023].
34. European Medicines Agency. Repurposing of authorised medicines: pilot to support not-for-profit organisations and academia.
Available from: https://www.ema.europa.eu/en/news/repurposing-authorised-medicines-pilot-support-not-profit-organisations-
academia [Last accessed on 11 Apr 2023].
35. IRDiRC. Shared molecular etiologies underlying multiple rare diseases. Available from: https://irdirc.org/shared-molecular-etiologies/
[Last accessed on 11 Apr 2023].
36. IRDiRC. Pluto Project. Disregarded rare diseases. Available from: https://irdirc.org/pluto-project-disregarded-rare-diseases/ [Last
accessed on 11 Apr 2023].
37. IRDiRC. Vision & goals. Available from: https://irdirc.org/about-us/vision-goals/ [Last accessed on 11 Apr 2023].